5.30
price down icon0.66%   -0.04
after-market 시간 외 거래: 5.30
loading
전일 마감가:
$5.34
열려 있는:
$5.31
하루 거래량:
821.82K
Relative Volume:
1.60
시가총액:
$1.19B
수익:
$596.48M
순이익/손실:
$123.72M
주가수익비율:
9.6645
EPS:
0.5484
순현금흐름:
$106.59M
1주 성능:
-1.21%
1개월 성능:
-2.66%
6개월 성능:
+49.02%
1년 성능:
+95.76%
1일 변동 폭
Value
$5.285
$5.33
1주일 범위
Value
$5.285
$5.38
52주 변동 폭
Value
$2.37
$5.72

큐어백 Stock (CVAC) Company Profile

Name
명칭
Curevac N V
Name
전화
-
Name
주소
-
Name
직원
1,088
Name
트위터
Name
다음 수익 날짜
2025-08-18
Name
최신 SEC 제출 서류
Name
CVAC's Discussions on Twitter

CVAC을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
CVAC
Curevac N V
5.30 1.20B 596.48M 123.72M 106.59M 0.5484
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
421.67 109.22B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
628.00 67.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
423.47 57.35B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
831.48 50.87B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
182.77 39.72B 447.02M -1.18B -868.57M -6.1812

큐어백 Stock (CVAC) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-06-13 다운그레이드 Jefferies Buy → Hold
2024-04-25 다운그레이드 Leerink Partners Outperform → Market Perform
2023-06-08 개시 SVB Securities Outperform
2023-01-19 업그레이드 UBS Neutral → Buy
2023-01-09 업그레이드 Jefferies Hold → Buy
2022-01-21 다운그레이드 BofA Securities Neutral → Underperform
2022-01-18 개시 JMP Securities Mkt Outperform
2021-10-22 개시 Deutsche Bank Hold
2021-06-17 다운그레이드 BofA Securities Buy → Neutral
2021-04-26 재개 Credit Suisse Underperform
2021-04-26 개시 Guggenheim Neutral
2020-12-10 다운그레이드 Credit Suisse Neutral → Underperform
2020-09-08 개시 BofA Securities Buy
2020-09-08 개시 Credit Suisse Neutral
2020-09-08 개시 Jefferies Hold
모두보기

큐어백 주식(CVAC)의 최신 뉴스

pulisher
07:49 AM

Alpine Associates Management Inc. Makes New Investment in CureVac N.V. $CVAC - MarketBeat

07:49 AM
pulisher
06:25 AM

Will CureVac N.V. stock benefit from green energy trendsJuly 2025 Volume & Community Consensus Stock Picks - newser.com

06:25 AM
pulisher
06:13 AM

Applying big data sentiment scoring on CureVac N.V.Weekly Trade Recap & Breakout Confirmation Alerts - newser.com

06:13 AM
pulisher
06:06 AM

Smart tools for monitoring CureVac N.V.’s price action2025 Market Sentiment & Free Reliable Trade Execution Plans - newser.com

06:06 AM
pulisher
05:22 AM

Understanding CureVac N.V.’s price movementQuarterly Performance Summary & Expert-Curated Trade Recommendations - newser.com

05:22 AM
pulisher
Nov 03, 2025

BioNTech (NASDAQ: BNTX) reports €1,518.9M revenue, net loss €28.7M; raises FY outlook - Stock Titan

Nov 03, 2025
pulisher
Nov 03, 2025

Relative strength of CureVac N.V. in sector analysisMarket Movers & AI Enhanced Execution Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Why CureVac N.V. stock is a value investor pickWeekly Trade Report & Long-Term Safe Return Strategies - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Historical volatility pattern of CureVac N.V. visualized2025 Institutional Moves & Free Daily Entry Point Trade Alerts - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Analyzing net buyer seller activity in CureVac N.V.Portfolio Gains Summary & Real-Time Market Trend Scan - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Using data tools to time your CureVac N.V. exitJuly 2025 Short Interest & Verified High Yield Trade Plans - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

How interest rate cuts could boost CureVac N.V. stockMarket Risk Summary & Weekly Momentum Stock Picks - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Can CureVac N.V. stock resist market sell offsRisk Management & Technical Confirmation Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

How currency fluctuations impact CureVac N.V. stock2025 AllTime Highs & Free Reliable Trade Execution Plans - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Is CureVac N.V. stock positioned for digital transformation2025 EndofYear Setup & Growth Focused Stock Pick Reports - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

CureVac’s New mRNA Study: A Potential Game-Changer in Lung Cancer Treatment - MSN

Oct 30, 2025
pulisher
Oct 30, 2025

CureVac Announces Extraordinary Meeting for Merger with BioNTech - MSN

Oct 30, 2025
pulisher
Oct 29, 2025

CureVac N.V. (NASDAQ:CVAC) Given Average Recommendation of "Hold" by Analysts - MarketBeat

Oct 29, 2025
pulisher
Oct 28, 2025

Is CureVac N.V. stock supported by strong fundamentalsOptions Play & Safe Capital Growth Plans - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 27, 2025

Is CureVac N.V. stock ready for breakoutMarket Activity Report & Risk Controlled Swing Trade Alerts - fcp.pa.gov.br

Oct 27, 2025

큐어백 (CVAC) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$37.84
price up icon 1.29%
$28.80
price up icon 0.40%
$103.03
price up icon 1.23%
$104.48
price up icon 0.56%
biotechnology ONC
$309.92
price down icon 0.56%
$182.91
price down icon 1.57%
자본화:     |  볼륨(24시간):